CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test
Short Name: CDHR1 CORD15 NGS
Also known as: Cone-Rod Dystrophy 15 Genetic Test, CDHR1 Gene Sequencing, CORD15 NGS Test
CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically available within 3 to 4 weeks after sample collection.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last updated: September 7, 2026
Overview
To detect mutations in the CDHR1 gene associated with Cone-Rod Dystrophy Type 15, confirm a clinical diagnosis, assess carrier status, and guide genetic counseling and family planning. NGS genetic DNA test detecets for variant and mutation detection in CDHR1 gene for Cone-rod dystrophy type 15
- Test Code
- 3814
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- Reports are typically available within 3 to 4 weeks after sample collection.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Cone-rod dystrophy type 15 is a rare genetic disorder that affects the retina of the eye. It is caused by mutations in the CDHR1 gene, which is responsible for the production of a protein that plays a crucial role in the development and maintenance of the photoreceptor cells in the retina. Cone-rod dystrophy type 15 is an autosomal recessive disorder, which means that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disorder.
The symptoms of cone-rod dystrophy type 15 can vary depending on the severity and progression of the disorder. The most common symptoms include:
- Loss of central vision
- Difficulty distinguishing colors
- Night blindness
- Reduced visual acuity
- Sensitivity to light
Diagnosis of cone-rod dystrophy type 15 can be confirmed through genetic testing. NGS genetic DNA testing is a highly effective method for identifying mutations in the CDHR1 gene. This test can also be used to diagnose other types of cone-rod dystrophy and related disorders.
The cost of CDHR1 Gene Cone-rod dystrophy type 15 NGS Genetic DNA Test at DNA Labs India is INR 20,000. The test involves the collection of a blood or saliva sample, which is then analyzed in a laboratory using advanced sequencing technology.
Early diagnosis of cone-rod dystrophy type 15 can help individuals and their families to better understand the disorder and its progression. This can lead to more effective management of the symptoms and improved quality of life. Genetic testing can also provide valuable information for family planning and genetic counseling.
At DNA Labs India, we offer a wide range of genetic testing services to help individuals and families better understand their genetic makeup and the potential risks for inherited disorders. Our team of experienced genetic counselors and laboratory technicians are committed to providing accurate and reliable testing services at an affordable cost.
If you or a loved one are experiencing symptoms of cone-rod dystrophy type 15 or other related disorders, contact us today to learn more about how genetic testing can help.
The CDHR1 gene encodes a protein called Cadherin-Related Family Member 1 (CDHR1), which is involved in the development and maintenance of photoreceptor cells in the retina.
Mutations in the CDHR1 gene can lead to Cone-Rod Dystrophy Type 15, which is characterized by the degeneration of cone and rod cells in the retina, leading to vision impairment.
NGS (Next-Generation Sequencing) genetic DNA tests are used to analyze the DNA sequence of genes like CDHR1 to identify any mutations or variants that may be associated with Cone-Rod Dystrophy Type 15.
If you or someone you know is considering genetic testing for Cone-Rod Dystrophy related to the CDHR1 gene, I recommend consulting with an ophthalmologist (eye specialist), a medical geneticist, or a genetic counselor. They can provide accurate and current information about the condition, the implications of genetic testing, and any available treatment options. Medical knowledge can evolve, so it's important to rely on expert guidance for the latest information.
Sample Collection
No special preparation is required. Provide relevant clinical history and documentation if available.
Method: Venipuncture or Dried Blood Spot
Laboratory Analysis
A blood sample will be drawn by a trained phlebotomist. If providing a saliva sample, follow the instructions on the collection kit. For FTA card, a drop of blood from a finger prick is collected.
Report Delivery
You can resume normal activities immediately. Results are typically available within 3 to 4 weeks.
Timeline: Reports are typically available within 3 to 4 weeks after sample collection.
Patient Instructions
About This Test
Who Should Get This Test
To detect mutations in the CDHR1 gene associated with Cone-Rod Dystrophy Type 15, confirm a clinical diagnosis, assess carrier status, and guide genetic counseling and family planning.
NGS genetic DNA test detecets for variant and mutation detection in CDHR1 gene for Cone-rod dystrophy type 15
How to Prepare
- No fasting required.
- Maintain hydration before blood collection.
- Please bring any prior medical records or genetic counseling report.
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Genetic testing for CDHR1-related cone-rod dystrophy can identify at-risk family members and provide crucial information for reproductive planning. We recommend that all patients undergo pre-test and post-test genetic counseling to fully understand the implications of their results."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed blood sample
- Inadequate sample quantity
- Unlabelled or mislabelled sample
- Improperly stored or transported sample
Understanding Your Results
Negative (No pathogenic variant detected)
No disease-causing variant was found in the CDHR1 gene. A negative result does not completely exclude cone-rod dystrophy type 15, especially if clinical suspicion is high. Other genetic causes should be considered.
Positive (Pathogenic variant detected)
A disease-causing variant was identified in the CDHR1 gene, confirming the clinical diagnosis of cone-rod dystrophy type 15. This result is informative for family studies and reproductive decisions.
Variant of Unknown Significance (VUS)
A genetic variant was found whose significance is not yet clear. Additional testing of family members and further research may help classify the variant.
Consult your ophthalmologist or medical geneticist if you experience visual symptoms such as progressive loss of central vision, night blindness, or difficulty with colors, especially if there is a family history of retinal dystrophy.
Limitations
- ⚠NGS may not detect all types of mutations such as deep intronic variants or large structural rearrangements
- ⚠Variant calling may require confirmation by Sanger sequencing
- ⚠Test is specific to the CDHR1 gene and does not rule out other genetic causes of cone-rod dystrophy
Risks & Considerations
- ●Minimal risk of bleeding or bruising at the injection site
- ●Potential psychological impact from learning genetic status
Interfering Factors
- ●Poor quality or degraded DNA
- ●Sample contamination
- ●Low DNA concentration
- ●Large genomic rearrangements not detected by standard NGS
Frequently Asked Questions
What is the CDHR1 Gene Cone-Rod Dystrophy Type 15 NGS Genetic Test?
What does the CDHR1 gene do?
Who should get this test?
What are the symptoms of cone-rod dystrophy type 15?
How is this test performed?
What samples can be used for this test?
How long does the test take?
What is the cost of the test?
Does this test require fasting?
What do positive test results mean?
Can this test be used for family planning decisions?
Are home sample collection services available?
Related Tests
Leber's Hereditary Optic Neuropathy (LHON) Mitochondrial Mutation Detection Test
₹25,000Nx Gen Sequencing: Cataract Test
₹28,665Nx Gen Sequencing: Glaucoma Test
₹28,665Nx Gen Sequencing: Corneal Dystrophy Test
₹28,665Nx Gen Sequencing: Leber Congenital Amaurosis Test
₹28,665Nx Gen Sequencing: Ophthalmoplegia Test
₹28,665Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.